Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics.
Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes.It was founded in 2016 and is headquartered in San Francisco, California.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 5, 2021 | Seed | $5.90M | 4 |
Khosla Ventures
SV Latam Capital
|
— | Detail |
| Aug 22, 2019 | Seed | — | 4 | — | — | Detail |
| May 1, 2017 | Grant | — | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Khosla Ventures
|
Yes | Seed |
SV Latam Capital
|
Yes | Seed |
Sand Hill Angels
|
— | Seed |
Y Combinator
|
— | Seed |
Formic Ventures
|
— | Seed |
MedTech Innovator
|
— | Grant |